Jane Street’s Acceleron Pharma XLRN Stock Holding History

Jane Street’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-227,600	Closed	-$39.2M	–	11222
2021 Q3	$39.2M	Buy	227,600 +204,700	+894%	+$26.8M	0.01%	706
2021 Q2	$2.87M	Buy	22,900 +15,800	+223%	+$1.99M	﹤0.01%	3646
2021 Q1	$963K	Sell	7,100 -300	-4%	-$38.8K	﹤0.01%	5526
2020 Q4	$947K	Sell	7,400 -5,400	-42%	-$633K	﹤0.01%	4751
2020 Q3	$1.44M	Sell	12,800 -31,700	-71%	-$3.16M	﹤0.01%	3523
2020 Q2	$4.24M	Sell	44,500 -9,900	-18%	-$954K	﹤0.01%	2060
2020 Q1	$4.89M	Buy	+54,400	New	+$4.23M	﹤0.01%	1199

Jane Street's XLRN Position: Q4 2021 in Review

Jane Street sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 41,054 shares — an estimated $7.07M sold.

Jane Street first reported a position in XLRN in Q2 2014 and held it in 14 quarters. The position peaked at $11.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Jane Street reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Jane Street sold 41,054 Acceleron Pharma shares in Q4 2021, an estimated $7.07M.
Jane Street first reported a position in Acceleron Pharma in Q2 2014 and held it in 14 quarters.
Jane Street's Acceleron Pharma position peaked at $11.5M in Q2 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.